Science vs Cell: Which Journal Should You Choose?

Science and Cell are both elite journals for life sciences research, but they have different scopes and editorial philosophies. Science is multidisciplinary and accepts work across all fields, including engineering and policy. Cell focuses exclusively on cellular and molecular biology. Knowing which fits your paper prevents wasted time and early rejections.

Related: How to choose a journal • Science impact factor • Cell impact factor • Avoid desk rejection

Impact Factor and Prestige

Science has a slight edge: JIF 45.8 vs. Cell's JIF 42.5 (2024 JCR). The difference is small—both are in the elite tier. Prestige-wise, both are career-making publications. In hiring and grant contexts, they're treated as equivalent.

Scope: The Critical Difference

Science is a true multidisciplinary journal. It publishes research in biology, chemistry, physics, geology, engineering, medicine, and more. The editorial bar is about novelty and significance, not disciplinary fit. A breakthrough paper in systems neuroscience, genomics, chemical engineering, or climate science can all land in Science.

Cell is disciplinary: it publishes cell and molecular biology research—signaling, gene regulation, protein function, cell cycle, autophagy, cancer biology, developmental biology, and related areas. The journal does not publish ecology, organismal biology without cellular/molecular mechanism, pure computational work, or engineering unrelated to cell biology.

This is the key decision point. If your work is about cellular or molecular mechanisms, both journals could work. If it's organismal, ecological, or outside biology, Science is the only option.

Specialty Within Life Sciences

Cell is particularly strong in:

• Mechanistic cell biology and signaling
• Gene regulation and transcription
• Cancer and developmental biology
• Immunology and infection biology
• Protein biochemistry and structure

Science is equally strong in those areas but also publishes:

• Organismal and evolutionary biology
• Neuroscience and behavior
• Ecology and environmental science
• Medicine and clinical research
• Chemistry and materials science
• Physics and astronomy

If your work spans multiple disciplines or is outside pure cell/molecular biology, Science is the better target.

Editorial Philosophy

Science looks for papers that advance understanding in any field. The story can be broad ("how do animals navigate?") or specific ("new mechanism in signaling"). As long as the work is novel and rigorous, it fits.

Cell expects papers to provide mechanistic insight into cellular processes. Descriptive work—even novel description—doesn't fit as well. A paper characterizing a new cell type is interesting; a paper showing _how that cell type functions_ is Cell material.

Practical example: a study identifying a new immune cell subset with single-cell RNA-seq could go to Science. A study showing how that cell subset exerts its function mechanistically fits Cell better.

Acceptance Rate and Timeline

Both accept roughly 5-7% of submissions. Both take 3-6 months to decision. No meaningful difference.

How to Decide

Use this decision tree:

1. Is your work primarily about cellular or molecular mechanisms? If yes, both journals could work. Proceed to step 2. If no (organismal, ecology, physics, etc.), submit to Science only.
2. How broad is your story? If it's a focused mechanistic discovery, Cell. If it's broader (with or without cellular insights), Science.
3. What's your field's publishing pattern? Check recent issues. Where do similar papers from your field typically publish? That's a signal of fit.
4. If both fit, which are you more excited about? Pick one and submit. Both are legitimate targets.

Examples

Better fit for Cell:

• Discovery of a new signaling pathway controlling cell proliferation
• Mechanistic study of how a transcription factor regulates gene expression
• Novel CRISPR application that reveals cellular function
• Study of how a virus hijacks cellular machinery

Better fit for Science:

• New animal behavior driven by evolved neural circuits (neuroscience + behavior)
• Discovery of how climate change alters ecosystem composition
• New materials with novel properties and engineering application
• Clinical study showing a new therapeutic approach with mechanistic support

Could fit either:

• Discovery of a new immune cell function with molecular mechanistic insight
• Developmental biology study revealing a gene regulatory network
• Cancer biology study identifying a new therapeutic target

Rejected from One, Try the Other?

If Cell rejects your paper, Science is worth trying if the work is rigorous—Cell's rejection might be about scope rather than quality. But if Science also rejects, the issue is probably more fundamental (rigor, novelty, or incomplete data).

If Science rejects, Cell won't fix it unless the rejection was about scope, not quality.

Final Thoughts

Both journals are legitimate targets for high-impact life sciences work. The decision comes down to scope: if your work is cellular/molecular _and_ you've done rigorous mechanistic work, Cell is an excellent target. If your work is broader or outside cell biology, Science is the right choice. Don't overthink it—submit where the fit is clearest and handle rejection gracefully if it comes.